Sclerotia formed by citric acid producing strains of Aspergillus niger: Induction and morphological analysis.


Journal

Fungal biology
ISSN: 1878-6146
Titre abrégé: Fungal Biol
Pays: Netherlands
ID NLM: 101524465

Informations de publication

Date de publication:
06 2021
Historique:
received: 15 09 2020
revised: 22 01 2021
accepted: 25 01 2021
entrez: 24 5 2021
pubmed: 25 5 2021
medline: 4 9 2021
Statut: ppublish

Résumé

Some strains of Aspergillus niger have been previously reported to produce sclerotia under certain conditions. Sclerotia are aggregations of hyphae which can act either as survival or as sexual structures in species related to A. niger. In this study, we were able to induce the formation of sclerotia in the progenitor of the industrial citric acid producing strains of A. niger, ATCC 1015, and in pyrG mutants derived from it. Sclerotia can be stably formed by ATCC 1015 on malt extract agar medium supplemented with raisins, showing a spatial differentiation of the fungus dependent on the addition and on the position of the fruits into the medium. On other media, including malt extract agar, pyrG auxotrophs also form abundant sclerotia, while the complementation of this gene reverses this phenotype. Additionally, a macro- and microscopical analysis of the sclerotia is reported. Our results show that the sclerotia formed by A. niger are similar to those formed by other fungi, not only in their morphology but also in their ability to germinate and regenerate the organism.

Identifiants

pubmed: 34024596
pii: S1878-6146(21)00015-5
doi: 10.1016/j.funbio.2021.01.008
pii:
doi:

Substances chimiques

Citric Acid 2968PHW8QP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

485-494

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no competing interests.

Auteurs

Valeria Ellena (V)

Austrian Centre of Industrial Biotechnology (ACIB GmbH), Muthgasse 18, Vienna, Austria; Institute of Microbiology and Microbial Biotechnology, BOKU-VIBT, University of Natural Resources and Life Sciences, Muthgasse 18, Vienna, Austria; Institute of Chemical, Environmental and Bioscience Engineering, TU Wien, Vienna, Austria.

Daniela Bucchieri (D)

Institute of Microbiology and Microbial Biotechnology, BOKU-VIBT, University of Natural Resources and Life Sciences, Muthgasse 18, Vienna, Austria.

Elsa Arcalis (E)

Department of Applied Genetics and Cell Biology (DAGZ), University of Natural Resources and Life Sciences, Muthgasse 11, Vienna, Austria.

Michael Sauer (M)

Austrian Centre of Industrial Biotechnology (ACIB GmbH), Muthgasse 18, Vienna, Austria; Institute of Microbiology and Microbial Biotechnology, BOKU-VIBT, University of Natural Resources and Life Sciences, Muthgasse 18, Vienna, Austria; CD Laboratory for Biotechnology of Glycerol, Muthgasse 18, Vienna, Austria.

Matthias G Steiger (MG)

Austrian Centre of Industrial Biotechnology (ACIB GmbH), Muthgasse 18, Vienna, Austria; Institute of Microbiology and Microbial Biotechnology, BOKU-VIBT, University of Natural Resources and Life Sciences, Muthgasse 18, Vienna, Austria; Institute of Chemical, Environmental and Bioscience Engineering, TU Wien, Vienna, Austria. Electronic address: matthias.steiger@tuwien.ac.at.

Articles similaires

T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

Prevalence and implications of fragile X premutation screening in Thailand.

Areerat Hnoonual, Sunita Kaewfai, Chanin Limwongse et al.
1.00
Humans Fragile X Mental Retardation Protein Thailand Male Female
Humans Receptors, Antigen, T-Cell Proto-Oncogene Proteins p21(ras) Pancreatic Neoplasms T-Lymphocytes

Classifications MeSH